(Q43766266)

26 November 2017

title

Voltammetric studies of 2-hydroxy-5-[(4-sulfophenyl)azo]benzoic acid as a novel prodrug of 5-aminosalicylic acid (English)

1 reference

26 November 2017

Nigović B

1

1 reference

26 November 2017

Mandić Z

series ordinal

2

1 reference

26 November 2017

Simunić B

series ordinal

3

1 reference

26 November 2017

Fistrić I

series ordinal

4

1 reference

26 November 2017

publication date

1 December 2001

1 reference

Journal of Pharmaceutical and Biomedical Analysis

26 November 2017

published in

1 reference

26 November 2017

volume

26

1 reference

26 November 2017

issue

5-6

1 reference

26 November 2017

page(s)

987-994

1 reference

5-Aminosalicylate: oxidation by activated leukocytes and protection of cultured cells from oxidative damage

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects?

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

Second-line anti-rheumatic drugs and free radical scavenging

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

Sulfasalazine. Adverse effects and desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

A polymeric drug for treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

A comparison of the electrochemical properties of some azosalicylic acids at glassy carbon electrodes by cyclic and hydrodynamic voltammetry

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

Investigation of the degradation mechanism of 5-aminosalicylic acid in aqueous solution

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

A Comparative Study of the Oxidation of 3-, 4- and 5-Aminosalicylic Acids at Glassy Carbon Electrodes

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900463-0

7 January 2021

10.1016/S0731-7085(01)00463-0

Identifiers

DOI

1 reference

26 November 2017

1 reference